PATIENTS RECEIVING SHORT RUN-IN TREATMENT (similar to 2 MONTHS) WITH ABIRATERONE ACETATE AND PREDNISONE (AAP) SHOWED SIMILAR BENEFIT FROM NIRAPARIB AND AAP IN THE PHASE 3 MAGNITUDE STUDY WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER AND HRR GENE ALTERATIONS
ONCOLOGY NURSING FORUM(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要